Select Page

The Infinium Global Research analyzes the Biosimilar Market over the period of 2019 to 2025. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global biosimilar market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of biosimilar. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the biosimilar market during the period. The global biosimilar market is projected to grow at a CAGR of 35.12% over the forecast period of 2019-2025.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026. 

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

A biosimilar is a biological product with similar characteristics that are referred to as a biological product, which possesses approval from agencies such as the FDA. Biosimilar products are made of complex molecules with high molecular weight produced through genetic engineering in living cells. Biosimilar drugs can save around 30 to 40 % in terms of price relative to the respective biologics drugs. Biosimilar is useful for the treatment of illnesses such as anemia, autoimmune diseases, cancer, diabetes, growth hormone deficiencies, hematological diseases, kidney failure, rheumatoid arthritis, and others. The substitution of biological drugs with biosimilar drugs can save a lot of money for the public health care sector and patients.

Increasing Awareness about Biosimilar among the Patients and Doctors is a Major Factor for the Growth of the Global Biosimilar Market 

Increasing awareness about biosimilar among the patients and doctors is a major factor for the growth of the global biosimilar market. The presence of a large number of geriatric population is expected to aid the growth of the global biosimilar market during the forecast period, as they need treatment for various chronical illnesses. An increasing number of patients with chronic illnesses such as diabetes and cancer drive the demand for effective patented biologics medicines. Due to the lower cost, biosimilar medicines are expected to attain more demand and drive the growth of the global biosimilar market during the forecast period. 

The reimbursement policies of various governments and the increasing interests of the insurance companies are expected to make biosimilar affordable to more people and drive the growth of the global biosimilar market. On the other side, the high manufacturing cost and complexity of production, along with the unclear regulatory policies in many countries are expected to be the major restraints for the global biosimilar. Besides, the expiry of patents of various blockbuster drugs is a major factor for the growth of the global biosimilar market, as it is expected to provide opportunities during the forecast period.

Get this Section as a Free Customization in the Report along with Discount on the Study:

European Market Holds a Major Share in the Biosimilar Market 

In terms of geographies, the European market holds a major share in the biosimilar market. Countries such as France, Germany, Italy, and United Kingdom drive the growth of the European biosimilar market due to the high demand for low-cost alternatives for biologics medicines. Further, the Asia-Pacific region has significant biosimilar in use due to the relaxed regulations in various countries. Due to the presence of a large population and the need for low-cost alternative medicines for various diseases in countries such as China, India, South Korea, and others drive the growth of the biosimilar market in Asia-Pacific. Moreover, the rate of approvals for a biosimilar is increasing at a faster pace in the U.S., due to this the North American region is expected to become the fastest growing biosimilar market during the forecast period.

Biosimilar Market: Segmentation

The report on global biosimilar market covers segments such as product and application. On the basis of product, the sub-markets include human growth hormones, monoclonal antibodies, insulin, peptides, erythropoietin, and other products. On the basis of application, the sub-markets include oncology, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases, and other application.

Biosimilar Market: Competitive Landscape

The report provides profiles of the companies in the market such as Allergan plc, BIOCAD, Biocon Limited, BioXpress Therapeutics SA, Boehringer Ingelheim International GmbH, Celltrion Inc, CoherusBioSciences, Inc, Dr. Reddy’s Laboratories Ltd, GenorBioPharma Co. Ltd, Intas Pharmaceuticals Limited, Novartis AG, and Other Companies.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Reasons to Buy this Report: 

  • Comprehensive analysis of global as well as regional markets of the biosimilar.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025. 
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.    
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.